Pharmacokinetics and Safety of Single-Dose Tenofovir Disoproxil Fumarate and Emtricitabine in HIV-1-Infected Pregnant Women and Their InfantsPatricia M. Flynn, Lynne Mofenson, D. Heather Watts et al.|Antimicrobial Agents and Chemotherapy|2011Cited by 57
Intracellular Pharmacokinetics of Once versus Twice Daily Zidovudine and Lamivudine in AdolescentsPatricia M. Flynn, Jaime Martinez, Jack Rodman et al.|Antimicrobial Agents and Chemotherapy|2007Cited by 25
Triggered Escalating Real-Time Adherence Intervention to Promote Rapid HIV Viral Suppression Among Youth Living With HIV Failing Antiretroviral Therapy: Protocol for a Triggered Escalating Real-Time Adherence InterventionK. Rivet Amico, Aditya H. Gaur, Amanda Dunlap et al.|JMIR Research Protocols|2019Cited by 21
Pharmacokinetics, safety, and tolerability of dispersible and immediate-release abacavir, dolutegravir, and lamivudine tablets in children with HIV (IMPAACT 2019): week 24 results of an open-label, multicentre, phase 1–2 dose-confirmation studyKristina M. Brooks, Patricia M. Flynn, Jennifer J. Kiser et al.|The Lancet HIV|2023Cited by 13
Efficacy, Safety and Tolerability of Dispersible and Immediate Release Abacavir/Dolutegravir/Lamivudine Tablets in Children With HIV: IMPAACT 2019 Week 48 ResultsDwight E. Yin, S. M. Ward, Yasha Rani et al.|The Pediatric Infectious Disease Journal|2025Cited by 1